Browsing by Titles

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 7 of 7

Article
Abrogation of the Circadian Nuclear Receptor REV-ERB alpha Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration
  • Kim, Jeongah ; 
  • Jang, Sang Won ; 
  • Choi, Mijung ; 
  • Chung, Soo Young ; 
  • Choe, Young Shik ; 
  • Choe, Han Kyoung ; 
  • Son, Gi Hoon ; 
  • Rhee, Kun Soo ; 
  • Kim, Kyungjin
  • 2018-08
  • Kim, Jeongah. (2018-08). Abrogation of the Circadian Nuclear Receptor REV-ERB alpha Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration. Molecules and Cells, 41(8), 742–752. doi: 10.14348/molcells.2018.0201
  • 한국분자세포생물학회
  • View : 933
  • Download : 0

Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson’s Disease Models

Article
Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson’s Disease Models
  • 2019-10
  • Cho, Bongki. (2019-10). Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson’s Disease Models. International Journal of Molecular Sciences, 20(20), 5208. doi: 10.3390/ijms20205208
  • Multidisciplinary Digital Publishing Institute (MDPI)
  • View : 767
  • Download : 114
Article
Closed-Loop Neuromodulation for Parkinson’s Disease: Current State and Future Directions
  • 2021-12
  • Kim, Samhwan. (2021-12). Closed-Loop Neuromodulation for Parkinson’s Disease: Current State and Future Directions. IEEE Transactions on Molecular, Biological, and Multi-Scale Communications, 7(4), 209–223. doi: 10.1109/TMBMC.2020.3036756
  • Institute of Electrical and Electronics Engineers Inc.
  • View : 927
  • Download : 0
Article
Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson’s disease
  • 2024-01
  • Park, Jeongrak. (2024-01). Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson’s disease. Frontiers in Bioengineering and Biotechnology, 12. doi: 10.3389/fbioe.2024.1335474
  • Frontiers Research Foundation
  • View : 523
  • Download : 0
Article
Implications of Circadian Rhythm in Dopamine and Mood Regulation
  • Kim, Jeongah ; 
  • Jang, Sangwon ; 
  • Choe, Han Kyoung ; 
  • Chung, Sooyoung ; 
  • Son, Gi Hoon ; 
  • Kim, Kyungjin
  • 2017-07
  • Kim, Jeongah. (2017-07). Implications of Circadian Rhythm in Dopamine and Mood Regulation. doi: 10.14348/molcells.2017.0065
  • 한국분자세포생물학회
  • View : 1212
  • Download : 0
Article
Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease
  • Jang, Han Nah ; 
  • Kim, Se Hwan ; 
  • Lee, Jae Man ; 
  • Oh, Yong Seok ; 
  • Park, Sang Myun ; 
  • Kim, Sang Ryong
  • 2017-03
  • Jang, Han Nah. (2017-03). Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease. NeuroReport, 28(5), 242–249. doi: 10.1097/WNR.0000000000000740
  • Lippincott Williams and Wilkins
  • View : 1142
  • Download : 0

Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo

Article
Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo
  • Kim, Sehwan ; 
  • Moon, Gyeong Joon ; 
  • Oh, Yong-Seok ; 
  • Park, Jungha ; 
  • Shin, Won-Ho ; 
  • Jeong, Jae Yeong ; 
  • Choi, Kwang Shik ; 
  • Jin, Byung Kwan ; 
  • Kholodilov, Nikolai ; 
  • Burke, Robert E ; 
    • et al
  • 2018-02
  • Experimental & Molecular Medicine, v.50, no.2, pp.e440
  • NLM (Medline)
  • View : 763
  • Download : 168
1